Co-administration increases relugolix exposure and risk of adverse reactions. If unavoidable, separate dosing by at least 6 hours and monitor frequently.
Source: NLP:relugolix
P-Gp Inhibitors (Oral) Interactions
2 interactions on record
Co-administration increases AUC and Cmax of relugolix, may increase risk of adverse reactions. Avoid use; if unavoidable, separate dosing by at least 6 hours and monitor.
Source: NLP:relugolix, estradiol hemihydrate, and norethindrone acetate